1. Home
  2. SXTP vs MNDR Comparison

SXTP vs MNDR Comparison

Compare SXTP & MNDR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo 60 Degrees Pharmaceuticals Inc.

SXTP

60 Degrees Pharmaceuticals Inc.

HOLD

Current Price

$1.64

Market Cap

3.9M

Sector

Health Care

ML Signal

HOLD

Logo Mobile-health Network Solutions Class A Ordinary Shares

MNDR

Mobile-health Network Solutions Class A Ordinary Shares

HOLD

Current Price

$0.61

Market Cap

4.4M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
SXTP
MNDR
Founded
2010
2016
Country
United States
Singapore
Employees
3
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.9M
4.4M
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
SXTP
MNDR
Price
$1.64
$0.61
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$14.10
N/A
AVG Volume (30 Days)
75.3K
194.9K
Earning Date
05-15-2026
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$33.92
$608,852.40
Revenue Next Year
$51.35
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.34
$0.58
52 Week High
$8.62
$5.42

Technical Indicators

Market Signals
Indicator
SXTP
MNDR
Relative Strength Index (RSI) 59.81 27.72
Support Level $1.55 N/A
Resistance Level $1.84 $0.97
Average True Range (ATR) 0.12 0.05
MACD 0.03 -0.00
Stochastic Oscillator 73.68 15.59

Price Performance

Historical Comparison
SXTP
MNDR

About SXTP 60 Degrees Pharmaceuticals Inc.

60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. Currently, company's pipeline under development covers development programs for vector-borne, fungal, and viral diseases utilizing three of the Company's future products: (i) new products that contain the Arakoda regimen of Tafenoquine; (ii) new products that contain Tafenoquine; and (iii) Celgosivir and/or botanical extracts from Australian Chestnut Trees.

About MNDR Mobile-health Network Solutions Class A Ordinary Shares

Mobile-health Network Solutions is a company engaged in providing telehealth solutions in terms of various matrices, such as the number of patient consultations per day and the ranking of its mobile application. It provides services on its MaNaDr platform, which is accessible via mobile application and website. The MaNaDr platform is a platform designed and created by doctors, for doctors and users, equipped with services like consultations with doctors, e-commerce pharma store, and others. The company's operating segments are Telemedicine and other services, and the Sale of medicine and medical devices. The majority of the company's revenue is derived from the Telemedicine and other services segment. Geographically, it derives revenue from Singapore.

Share on Social Networks: